Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool

por Krishnamurthy, Savitri, Jain, Parag, Tripathy, Debu, Basset, Roland, Randhawa, Ramandeep, Muhammad, Hassan, Huang, Wei, Yang, Hua, Kummar, Shivaani, Wilding, George, Roy, Rajat
Publicado 2023

Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021

por Pritchett, Joshua C., Borah, Bijan J., Dholakia, Ruchita, Moriarty, James P., Ahn, Hannah H., Huang, Ming, Khera, Nandita, Wilshusen, Laurie, Dronca, Roxana S., Ticku, Jonathan, Leppin, Aaron L., Tilburt, Jon C., Paludo, Jonas, Haddad, Tufia C.
Publicado 2023

Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformed

por Heald, Adrian H., Warner-Levy, John, Belston, Lleyton, Habete-Asres, Hellena, Horne, Linda, Metters, Ann, Whyte, Martin, Gibson, Martin
Publicado 2023

The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor...

por Kobayashi, Kazuo, Toyoda, Masao, Hatori, Nobuo, Tsukamoto, Shunichiro, Kimura, Moritsugu, Sakai, Hiroyuki, Furuki, Takayuki, Chin, Keiichi, Kanaoka, Tomohiko, Aoyama, Togo, Umezono, Tomoya, Ito, Shun, Suzuki, Daisuke, Takeda, Hiroshi, Degawa, Hisakazu, Hishiki, Toshimasa, Shimura, Hidetoshi, Nakajima, Shinichi, Miyauchi, Masaaki, Yamamoto, Hareaki, Hatori, Yutaka, Hayashi, Masahiro, Sato, Kazuyoshi, Miyakawa, Masaaki, Terauchi, Yasuo, Tamura, Kouichi, Kanamori, Akira
Publicado 2023

Cluster Randomized Pragmatic Clinical Trial Testing Behavioral Economic Implementation Strategies to Improve Tobacco Treatment for Patients With Cancer Who Smoke

por Jenssen, Brian P., Schnoll, Robert, Beidas, Rinad S., Bekelman, Justin, Bauer, Anna-Marika, Evers-Casey, Sarah, Fisher, Tierney, Scott, Callie, Nicoloso, Jody, Gabriel, Peter, Asch, David A., Buttenheim, Alison M., Chen, Jessica, Melo, Julissa, Grant, Dwayne, Horst, Michael, Oyer, Randall, Shulman, Lawrence N., Clifton, Alicia B.W., Lieberman, Adina, Salam, Tasnim, Rendle, Katharine A., Chaiyachati, Krisda H., Shelton, Rachel C., Fayanju, Oluwadamilola, Wileyto, E. Paul, Ware, Sue, Blumenthal, Daniel, Ragusano, Daniel, Leone, Frank T.
Publicado 2023

Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant C...

por Versluis, Jurjen, Saber, Wael, Tsai, Harrison K., Gibson, Christopher J., Dillon, Laura W., Mishra, Asmita, McGuirk, Joseph, Maziarz, Richard T., Westervelt, Peter, Hegde, Pranay, Mukherjee, Devdeep, Martens, Michael J., Logan, Brent, Horowitz, Mary, Hourigan, Christopher S., Nakamura, Ryotaro, Cutler, Corey, Lindsley, R. Coleman
Publicado 2023

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

por Oliva, Esther Natalie, Riva, Marta, Niscola, Pasquale, Santini, Valeria, Breccia, Massimo, Giai, Valentina, Poloni, Antonella, Patriarca, Andrea, Crisà, Elena, Capodanno, Isabella, Salutari, Prassede, Reda, Gianluigi, Cascavilla, Nicola, Ferrero, Dario, Guarini, Attilio, Tripepi, Giovanni, Iannì, Giuseppe, Russo, Emilio, Castelli, Andrea, Fattizzo, Bruno, Beltrami, Germana, Bocchia, Monica, Molteni, Alfredo, Fenaux, Pierre, Germing, Ulrich, Ricco, Alessandra, Palumbo, Giuseppe A., Impera, Stefana, Di Renzo, Nicola, Rivellini, Flavia, Buccisano, Francesco, Stamatoullas-Bastard, Aspasia, Liberati, Anna Marina, Candoni, Anna, Delfino, Ilaria Maria, Arcadi, Maria Teresa, Cufari, Patrizia, Rizzo, Lorenzo, Bova, Irene, D'Errigo, Maria Grazia, Zini, Gina, Latagliata, Roberto
Publicado 2023

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS(G12C)-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases

por Negrao, Marcelo V., Spira, Alexander I., Heist, Rebecca S., Jänne, Pasi A., Pacheco, Jose M., Weiss, Jared, Gadgeel, Shirish M., Velastegui, Karen, Yang, Wenjing, Der-Torossian, Hirak, Christensen, James G., Sabari, Joshua K.
Publicado 2023

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Bra...

por Nadal, Ernest, Rodríguez-Abreu, Delvys, Simó, Marta, Massutí, Bartomeu, Juan, Oscar, Huidobro, Gerardo, López, Rafael, De Castro, Javier, Estival, Anna, Mosquera, Joaquín, Sullivan, Ivana, Felip, Enriqueta, Blasco, Ana, Guirado, Maria, Pereira, Eva, Vilariño, Noelia, Navarro, Valentín, Bruna, Jordi
Publicado 2023

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma

por Faron, Matthieu, Cheugoua-Zanetsie, Maurice, Tierney, Jayne, Thirion, Pierre, Nankivell, Matthew, Winter, Kathryn, Yang, Hong, Shapiro, Joel, Vernerey, Dewi, Smithers, B. Mark, Walsh, Thomas, Piessen, Guillaume, Nilsson, Magnus, Boonstra, Jurjen, Ychou, Marc, Law, Simon, Cunningham, David, de Vathaire, Florent, Stahl, Michael, Urba, Susan, Valmasoni, Michele, Williaume, Danièle, Thomas, Janine, Lordick, Florian, Tepper, Joel, Roth, Jack, Gebski, Val, Burmeister, Bryan, Paoletti, Xavier, van Sandick, Johanna, Fu, Jianhua, Pignon, Jean-Pierre, Ducreux, Michel, Michiels, Stefan
Publicado 2023

First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lun...

por Shimizu, Toshio, Sands, Jacob, Yoh, Kiyotaka, Spira, Alexander, Garon, Edward B., Kitazono, Satoru, Johnson, Melissa L., Meric-Bernstam, Funda, Tolcher, Anthony W., Yamamoto, Noboru, Greenberg, Jon, Kawasaki, Yui, Zebger-Gong, Hong, Kobayashi, Fumiaki, Phillips, Penny, Lisberg, Aaron E., Heist, Rebecca S.
Publicado 2023

Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial

por Ascierto, Paolo A., Dummer, Reinhard, Gogas, Helen J., Arance, Ana, Mandala, Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsova, Ivana, Gutzmer, Ralf, Chiarion-Sileni, Vanna, Dutriaux, Caroline, de Groot, Jan Willem B., Yamazaki, Naoya, Loquai, Carmen, Robert, Caroline, Flaherty, Keith T.
Publicado 2023

Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years

por Wilkinson, Anna N., Ellison, Larry F., Billette, Jean-Michel, Seely, Jean M.
Publicado 2023

Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer

por Wadensten, Elisabeth, Wessman, Sandra, Abel, Frida, Diaz De Ståhl, Teresita, Tesi, Bianca, Orsmark Pietras, Christina, Arvidsson, Linda, Taylan, Fulya, Fransson, Susanne, Vogt, Hartmut, Poluha, Anna, Pradhananga, Sailendra, Hellberg, Maria, Lagerstedt-Robinson, Kristina, Raj Somarajan, Praveen, Samuelsson, Sofie, Orrsjö, Sara, Maqbool, Khurram, Henning, Karin, Strid, Tobias, Ek, Torben, Fagman, Henrik, Olsson Bontell, Thomas, Martinsson, Tommy, Puls, Florian, Kogner, Per, Wirta, Valtteri, Pronk, Cornelis Jan, Wille, Joakim, Rosenquist, Richard, Nistér, Monica, Mertens, Fredrik, Sabel, Magnus, Norén-Nyström, Ulrika, Grillner, Pernilla, Nordgren, Ann, Ljungman, Gustaf, Sandgren, Johanna, Gisselsson, David
Publicado 2023

Margin to Depth of Invasion Ratio: A Significant Predictor of Survival in Patients With Oral Cancer

por Sultania, Mahesh, Chaudhary, Itisha, Jain, Priyansh, Ghalige, Hemanth, Rajan, Dipin, G, Sudhakar, K, Raghuram, Muduly, Dillip, Barik, Sandip, Pathak, Mona, Adhya, Amit, Kar, Madhabananda, Majumdar, Saroj
Publicado 2023

D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms

por Porcelli, Tommaso, Moccia, Marialuisa, De Stefano, Maria Angela, Ambrosio, Raffaele, Capoluongo, Ettore, Santoro, Massimo, Hadoux, Julien, Schlumberger, Martin, Carlomagno, Francesca, Salvatore, Domenico
Publicado 2023

Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma

por Christinat, Yann, Ho, Liza, Clément, Sophie, Genestie, Catherine, Sehouli, Jalid, Cinieri, Saverio, Gonzalez Martin, Antonio, Denison, Ursula, Fujiwara, Keiichi, Vergote, Ignace, Tognon, Germana, Hietanen, Sakari, Ray-Coquard, Isabelle, Pujade-Lauraine, Eric, McKee, Thomas A.
Publicado 2023

To Chemo or Not to Chemo… That Is the Question

por Martin, Maria Felisa Eva B., Ting, Frederic Ivan L.
Publicado 2023

Reply to A. Mangla

por Mansha, Muhammad A., Abbasi, Ahmed N., Fareed, Muhammad M.
Publicado 2023

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer

por Desai, Neelam V., Barrows, Elizabeth D., Nielsen, Sarah M., Hatchell, Kathryn E., Anderson, Michael J., Haverfield, Eden V., Herrera, Blanca, Esplin, Edward D., Lucassen, Anneke, Tung, Nadine M., Isaacs, Claudine
Publicado 2023